Retreatment with peginterferon and ribavirin in chronic hepatitis C

来源 :World Journal of Gastroenterology | 被引量 : 0次 | 上传用户:seemo
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
The development of boceprevir and telaprevir was a major step forward in the treatment of chronic hepatitis C.In addition,the treatment of these infections has been recently revolutionized by the approval of sofosbuvir and simeprevir.However,there are several challenges associated with the application of noveldrugs,such as new and more frequent adverse events,new drug interactions,and excessively high treatment costs.An additional concern is viral resistance.These considerations highlight the fact that direct-acting antiviral agents are not a panacea and may not be the best option for all patients who are in need of therapy.This retrospective study revealed that the sustained virologic response was not significantly reduced following peginterferon and ribavirin retreatment compared with the new therapy.We suggest that patients who experience relapse shortly after completing treatment with peginterferon and ribavirin have a reasonable chance of achieving a sustained virologic response when retreated with these drugs alone. The development of boceprevir and telaprevir was a major step forward in the treatment of chronic hepatitis C. In addition, the treatment of these infections has been recently revolutionized by the approval of sofosbuvir and simeprevir. However, there are several challenges associated with the application of of noveldrugs, such as new and more frequent adverse events, new drug interactions, and excessively high treatment costs. An additional concern is viral resistance. These factors highlight the fact that direct-acting antiviral agents are not a panacea and may not be the best option for all patients who are in need of therapy. This retrospective study revealed that the sustained virologic response was not significant reduced following peginterferon and ribavirin retreatment compared with the new therapy. We suggest that patients who experience relapse shortly after completing treatment with peginterferon and ribavirin have a reasonable chance of achieving a sustained virologic response w hen retreated with these drugs alone.
其他文献
为了全面完成社区整合工作,研究探索县(市)居委会整合的基本思路,福州市于7月中旬先后对福清、长乐、闽侯、闽清等县(市)的居委会现状进行了调研。总的感到,县(市)社区整合难
我今年37岁了,想和妻子离婚。我对她已经没有感情了,结婚六年,期间她公派出国一年,我又经常出差,两个人聚少离多,彼此之间的交流越来越少,没什么共同语言。而且她是北方人,和
最近,江门市出版修志工作11年来第一部地方志工作论文集《求索集》,由北京中国县镇年鉴社结集出售发行。《求索集》由江门市地方史志办公室和江门市地方志学会联合结辑。该书共
前几日去办事,正好路遏十几年前的老邻居大宋。熟人相遇,自然热情攀谈起来。大宋问我是否还记得一个叫“白梅”的人,说人家现在发达了。我努力搜寻着,在我的记忆里似乎没有这个人。见状,大宋帮助我回忆起来:“咳,就是以前和我们住在一个大院里。那个又胖又矮,还有点罗圈腿的妇女……”听大宋这样一番描述,对方的形象一下子就在我的脑海里出现了。  事情巧得很。就在和大宋见面的一个星期之后,我竟然和那位“又胖又矮,还
据报导,在妇女黄体期给予LH-RH的高活性类似物([D-丝~6]-[去甘~(10)]-LH-RH乙基酰胺或[D-色~6]-[脯~9]-LH-RH乙基酰胺),可以缩短黄体期并使血浆孕酮浓度降低。这说明LHRH的
谋事之基成事之道《调研世界》《调研世界》杂志是国家统计局主管、国家统计局农村社会经济调查总队主办的国家级月刊,是全国经济类核心期刊,具有鲜明的调查研究特色。《调研世
环节一:停车问题 举例说明:某小区地下停车场试用阶段,物业公司对地下停车不收费。物业地下停车场设备设施完善后,物业公司宣布地下停车场实行有偿使用。部分业主认为地下停
对血浆及其衍生物中所含因子Ⅷ活性的测定,需要用不含因子Ⅷ的血浆作为基质。以往这类基质血浆均取自严重血友病患者,因而供应量有限。此外,这类血友病人血浆还可传播肝炎。
30名港台瘾君子在云南某医院戒除了毒瘾本刊讯过去不少国家和地区曾盛行“替代法”戒毒,即为患者注射或口服含少量毒品的药物,逐步减轻其对毒品的依赖。但此法治疗时间较长,巩固率
Q我刚24岁,原本在一家公司当职员。单位里有个三十多岁的男同事,因为工作的关系,我们比较熟,也比较谈得来。跟他在一起时,我可能比较放松,和他很随便。有一天下班后,办公室里